Stathmin 1 is a potential novel oncogene in melanoma

Oncogene

Volumn 32, Issue 10, 2013, Pages 1330-1337

  Chen, J ^a   Abi Daoud, M ^a   Wang, A ^a   Yang, X ^a   Zhang, X ^a   Feilotter, H E ^a   Tron, V A ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

melanoma; miR 193b; oncogene; STMN1

Indexed keywords

CYCLIN D1; LUCIFERASE; MESSENGER RNA; MICRORNA; PROTEIN MCL 1; PROTEIN P21; PROTEIN P27; SMALL INTERFERING RNA; TUBULIN;

3' UNTRANSLATED REGION; ARTICLE; BIOASSAY; CANCER SURVIVAL; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; COHORT ANALYSIS; CONTROLLED STUDY; DISASTER; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; MALE; MELANOMA; MELANOMA CELL; MICROTUBULE; MITOSIS; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REPORTER GENE; STATHMIN 1 GENE; TUMOR GROWTH; UPREGULATION;

3' UNTRANSLATED REGIONS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; HUMANS; MALE; MELANOMA; MICRORNAS; ONCOGENES; RNA, MESSENGER; STATHMIN; TRANSFECTION; UP-REGULATION;

LENTIVIRUS;

EID: 84874769369     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.141     Document Type: Article

References (51)

1. Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature 2007; 445: 851-857.
2. Rothhammer T, Bosserhoff AK. Epigenetic events in malignant melanoma. Pigment Cell Res 2007; 20: 92-111.
3. Miller AJ, Mihm Jr MC. Melanoma. N Engl J Med 2006; 355: 51-65.
4. Cohen C, Zavala-Pompa A, Sequeira JH, Shoji M, Sexton DG, Cotsonis G et al. Mitogen-actived protein kinase activation is an early event in melanoma progression. Clin Cancer Res 2002; 8: 3728-3733.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
6. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature 2008; 455: 64-71.
7. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58-63.
8. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
9. Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev 2011; 91: 827-887.
10. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
11. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
12. Chen J, Feilotter HE, Pare GC, Zhang X, Pemberton JG, Garady C et al. MicroRNA- 193b represses cell proliferation and regulates cyclin D1 in melanoma. Am J Pathol 2010; 176: 2520-2529.
13. Mueller DW, Rehli M, Bosserhoff AK. miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma. J Invest Dermatol 2009; 129: 1740-1751.
14. Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S et al. Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci USA 2009; 106: 1814-1819.
15. Boyle GM, Woods SL, Bonazzi VF, Stark MS, Hacker E, Aoude LG et al. Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell Melanoma Res 2011; 24: 525-537.
16. Levy C, Khaled M, Iliopoulos D, Janas MM, Schubert S, Pinner S et al. Intronic miR- 211 assumes the tumor suppressive function of its host gene in melanoma. Mol Cell 2010; 40: 841-849.
17. Chen J, Zhang X, Lentz C, Abi-Daoud M, Pare GC, Yang X et al. miR-193b Regulates Mcl-1 in Melanoma. Am J Pathol 2011; 179: 2162-2168.
18. Li XF, Yan PJ, Shao ZM. Downregulation of miR-193b contributes to enhance urokinase-Type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene 2009; 28: 3937-48.
19. Leivonen SK, Makela R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K et al. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene 2009; 28: 3926-36.
20. Rauhala HE, Jalava SE, Isotalo J, Bracken H, Lehmusvaara S, Tammela TL et al. miR- 193b is an epigenetically regulated putative tumor suppressor in prostate cancer. Int J Cancer 2010; 127: 1363-1372.
21. Xu C, Liu S, Fu H, Li S, Tie Y, Zhu J et al. MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cells. Eur J Cancer 2010; 46: 2828-2836.
22. Curmi PA, Gavet O, Charbaut E, Ozon S, Lachkar-Colmerauer S, Manceau V et al. Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubulin. Cell Struct Funct 1999; 24: 345-357.
23. Belletti B, Nicoloso MS, Schiappacassi M, Berton S, Lovat F, Wolf K et al. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential. Mol Biol Cell 2008; 19: 2003-2013.
24. Bieche I, Lachkar S, Becette V, Cifuentes-Diaz C, Sobel A, Lidereau R et al. Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer 1998; 78: 701-709.
25. Chen G, Wang H, Gharib TG, Huang CC, Thomas DG, Shedden KA et al. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas. Mol Cell Proteomics 2003; 2: 107-116.
26. Ghosh R, Gu G, Tillman E, Yuan J, Wang Y, Fazli L et al. Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression. Prostate 2007; 67: 1038-1052.
27. Hsieh SY, Huang SF, Yu MC, Yeh TS, Chen TC, Lin YJ et al. Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Mol Carcinog 2010; 49: 476-487.
28. Jeon TY, Han ME, Lee YW, Lee YS, Kim GH, Song GA et al. Overexpression of stathmin1 in the diffuse type of gastric cancer and its roles in proliferation and migration of gastric cancer cells. Br J Cancer 2010; 102: 710-718.
29. Singer S, Malz M, Herpel E, Warth A, Bissinger M, Keith M et al. Coordinated expression of stathmin family members by far upstream sequence elementbinding protein-1 increases motility in non-small cell lung cancer. Cancer Res 2009; 69: 2234-2243.
30. Zheng P, Liu YX, Chen L, Liu XH, Xiao ZQ, Zhao L et al. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer. J Proteome Res 2010; 9: 4897-4905.
31. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
32. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115: 787-798.
33. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
34. Akslen LA, Angelini S, Straume O, Bachmann IM, Molven A, Hemminki K et al. BRAF and NRAS mutations are frequent in nodular melanoma but are not associated with tumor cell proliferation or patient survival. J Invest Dermatol 2005; 125: 312-317.
35. Edlundh-Rose E, Egyhazi S, Omholt K, Mansson-Brahme E, Platz A, Hansson J et al. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res 2006; 16: 471-478.
36. Slipicevic A, Holm R, Nguyen MT, Bohler PJ, Davidson B, Florenes VA. Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome. Am J Clin Pathol 2005; 124: 528-536.
37. Howell B, Larsson N, Gullberg M, Cassimeris L. Dissociation of the tubulinsequestering and microtubule catastrophe-promoting activities of oncoprotein 18/stathmin. Mol Biol Cell 1999; 10: 105-118.
38. Andersen SS, Ashford AJ, Tournebize R, Gavet O, Sobel A, Hyman AA et al. Mitotic chromatin regulates phosphorylation of Stathmin/Op18. Nature 1997; 389: 640-643.
39. Cassimeris L. The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol 2002; 14: 18-24.
40. Niethammer P, Bastiaens P, Karsenti E. Stathmin-Tubulin interaction gradients in motile and mitotic cells. Science 2004; 303: 1862-1866.
41. Buhusi M, Midkiff BR, Gates AM, Richter M, Schachner M, Maness PF. Close homolog of L1 is an enhancer of integrin-mediated cell migration. J Biol Chem 2003; 278: 25024-25031.
42. Kamm KE, Stull JT. Dedicated myosin light chain kinases with diverse cellular functions. J Biol Chem 2001; 276: 4527-4530.
43. Li Z, Xu X, Bai L, Chen W, Lin Y. Epidermal growth factor receptor-mediated tissue transglutaminase overexpression couples acquired tumor necrosis factor-related apoptosis-inducing ligand resistance and migration through c-FLIP and MMP-9 proteins in lung cancer cells. J Biol Chem 2011; 286: 21164-21172.
44. Olaso E, Labrador JP, Wang L, Ikeda K, Eng FJ, Klein R et al. Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase- 2. J Biol Chem 2002; 277: 3606-3613.
45. Sun ZJ, Wang Y, Cai Z, Chen PP, Tong XJ, Xie D. Involvement of Cyr61 in growth, migration, and metastasis of prostate cancer cells. Br J Cancer 2008; 99: 1656-1667.
46. Kumar PS, Shiras A, Das G, Jagtap JC, Prasad V, Shastry P. Differential expression and role of p21cip/waf1 and p27kip1 in TNF-alpha-induced inhibition of proliferation in human glioma cells. Mol Cancer 2007; 6: 42.
47. Wellen J, Walter J, Jangouk P, Hartung HP, Dihne M. Neural precursor cells as a novel target for interferon-beta. Neuropharmacology 2009; 56: 386-398.
48. Fan T, Jiang S, Chung N, Alikhan A, Ni C, Lee CC et al. EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression. Mol Cancer Res 2011; 9: 418
49. Lauper N, Beck AR, Cariou S, Richman L, Hofmann K, Reith W et al. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cell cycle. Oncogene 1998; 17: 2637-2643.
50. Tong B, Grimes HL, Yang TY, Bear SE, Qin Z, Du K et al. The Gfi-1B proto-oncoprotein represses p21WAF1 and inhibits myeloid cell differentiation. Mol Cell Biol 1998; 18: 2462-2473.
51. Wang CH, Tsao YP, Chen HJ, Chen HL, Wang HW, Chen SL. Transcriptional repression of p21((Waf1/Cip1/Sdi1)) gene by c-jun through Sp1 site. Biochem Biophys Res Commun 2000; 270: 303-310.